Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Mutation Research. Reviews in Mutation Research|June 5, 2015
G-quadruplexes: A possible epigenetic target for nutritionMaxime François, Wayne Leifert, Ross Tellam, et al.Biotechniques|December 16, 2014
Automation of the cytokinesis-block micronucleus cytome assay by laser scanning cytometry and its potential application in radiation biodosimetryMaxime François, Kevin Hochstenbach, Wayne Leifert, et al.Proteomics|April 2, 2009
G-protein coupled receptor array technologies: site directed immobilisation of liposomes containing the H1-histamine or M2-muscarinic receptorsKelly Bailey, Marta Bally, Wayne Leifert, et al.Current Alzheimer Research|June 19, 2014
Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cellsMaxime François, Wayne Leifert, Ralph Martins, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 12, 2014
Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's diseaseMaxime François, Wayne Leifert, Jane Hecker, et al.Mutagenesis|December 18, 2010
Laser scanning cytometry for automation of the micronucleus assayZbigniew Darzynkiewicz, Piotr Smolewski, Elena Holden, et al.Inflammatory Intestinal Diseases|January 27, 2022
Epithelial-Specific TLR4 Knockout Challenges Current Evidence of TLR4 Homeostatic Control of Gut PermeabilityElise E Crame, Joanne M Bowen, Kate R Secombe, et al.Foods (Basel, Switzerland)|February 25, 2022
How Healthy Are Non-Traditional Dietary Proteins? The Effect of Diverse Protein Foods on Biomarkers of Human HealthCaroline Bull, Damien Belobrajdic, Sara Hamzelou, et al.Metabolites|December 27, 2024
Saliva Proteome, Metabolome and Microbiome Signatures for Detection of Alzheimer's DiseaseMaxime François, Dana Pascovici, Yanan Wang, et al.British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.Pageof 2